CLOs on the Move


 
VB Spine, LLC is a leading family-owned medical technology company focused on spine surgery products. Founded in April 2025 by the Viscogliosi Brothers, the company emerged from the acquisition of Stryker’s U.S. spinal implants business and has quickly expanded its international presence, including markets in Australia and New Zealand. The company is committed to enhancing patient outcomes through innovative, surgeon-driven solutions. VB Spine offers a wide range of specialized spine surgery products, including spinal implants and advanced technologies like the Stryker Mako Spine robotic system. Their patient-first approach ensures that healthcare professionals have access to the tools and resources needed to ...
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Diaserve Inc

Diaserve Inc is a Blooming Prairie, MN-based company in the Business Services sector.

Capstone Mechanical

Capstone Mechanical, Lp is a Waco, TX-based company in the Business Services sector.

University of Maryland Student Government Association

The Student Government Association (SGA) is the governance body for all undergraduate students at the University of Maryland, College Park. Composed of three branches - executive, legislative, and judicial - the organization works with various student groups, administrators, and government officials to ensure student interests are met. In order to make sure the voice of the student body is heard, members of the SGA reach out to their peers in class, campus events, and the office. The SGA implements legislation to remedy concerns and aid student groups with their missions and programming. Through efforts and outreach, the organization constantly works to improve our university.

AmpliPhi Biosciences

AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi`s product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (NYSE: XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester, to rapidly advance bacteriophage-based therapies.